• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
Back

Corporate News

Transgene Biotek reports no deviation statement needed for September quarter due to inactivity
03-Oct-2026, 07:40

Transgene Biotek Limited informed the Bombay Stock Exchange that the Statement of Deviation or Variation under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is not applicable for the quarter ended September 30, 2026, due to the absence of a public issue, rights’ issue, or preferential issue during that period.